MyProtection Prima II is a life insurance product with regular premium payments that provides protection for the insured until the age of 100 while also serving as an investment with a variety of investment sub-funds available in accordance with demands.
Additional Benefit Options (Rider) of MyProtection Prima II
* Cannot be taken together with Hospital and Surgical Care Plus.Allocation of Periodic Basic Premium* to be invested :
|Year 6 etc.
|Year 6 etc.
*) The Periodic Basic Premium which is allocated annually from your premium payment, will form the investment value of your policy.
Top Up Premium Allocation:
|Insured Entry Age
|1 month - 70 years old (nearest birthday).
|Policy Holder Entry Age
|Minimum 18 years old (nearest birthday).
|Rupiah dan US Dollar.
|Until the Insured reaches the Age of 100 years
|Premium Payment Period
|Up to the Insured Age 99 years old
|Premium Payment Method
The premium payment scheme is periodic premium (Annually, Semester, Quarterly, and Monthly)
|Minimum Periodic Basic Premium:
The amount of the Regular Basic Premium cannot be changed (added/deducted).
Minimum Periodic Top Up Premium :
Minimum Single Top Up Premium
Maximum Single Top Up Premium
Total Premium more than Rp2.000.000.000/ USD200.000 with financial underwriting.
Maximum Sum Assured for Children (up to 17 years old): IDR 3,000,000,000/USD 240,000.
|Product Illustration of MyProtection Prima II
30 th, does not smoke
A Manager in a company
The need to achieve dreams:
Assumed level of investment per year : -1%, 0%, 5%, dan 10%
Premium payment plan: 20 Years
|Benefit Illustration of MyProtection Prima II
Assumed level of investment per year
with 100% placement
at Smartlink Rupiah Equity
Class B Fund
30 years, does not smoke
The need to achieve dreams :
*) The investment value assumption that is formed is not guaranteed and can change at any time according to the investment performance of the Smartlink Rupiah Equity Class B Fund.
About Allianz Group
Allianz is one of the world's largest insurance and asset management providers. Together with customers and sales partners, Allianz is one of the strongest financial communities in the world with operations in 70 countries and supported by 150,000 employees serving more than 100 million individual and corporate customers.
About Allianz in Asia
Allianz has been present in Asia Pacific since 1910 on the coast of China by providing fire and freight insurance. Currently, Allianz operates in 16 countries in Asia Pacific to provide general insurance, life, health and asset management. With more than 36,000 staff, Allianz serves the needs of more than 21 million customers in the region through several distribution channels.
About Allianz in Indonesia
Allianz started its operations in Indonesia with a representative office in 1981. In 1989, Allianz established PT Asuransi Allianz Utama Indonesia, a general insurance company. Furthermore, Allianz entered the Indonesian life and health insurance market, as well as pension fund by opening PT Asuransi Allianz Life Indonesia in 1996.
In 2006, Allianz Utama and Allianz Life started sharia insurance business. Allianz Health & Corporate Solutions was formed in 2014 to serve the needs of individual and group health insurance. Supported by more than 1,300 employees and a network of more than 34,000 sales professionals as well as bank partners and other distribution channels. Today, Allianz in Indonesia is one of the leading insurance groups in the market trusted to protect more than 8,3 million insured.
PT Asuransi Allianz Life Indonesia is licensed and supervised by Otoritas Jasa Keuangan, and its Marketers hold a license from the Indonesian Life Insurance Association
Produk Asuransi Yang Dikaitkan dengan Investasi (PAYDI) MyProtection Prima II is an insurance product. The investment component in PAYDI contains risks. Prospective Policyholders must read and understand the General and RIPLAY Personal Product and Service Information Summary (RIPLAY) before deciding to buy PAYDI. PAYDI's past investment performance does not reflect PAYDI's future investment performance.